STAT Plus: A crucial study of Bellus Health’s chronic cough drug reads out soon. Here’s what you need to know
GEORGE MARKS/RETROFILE/GETTY IMAGES
With its Phase 2 study, the Canadian drug maker will learn whether it has a shot at developing a potential blockbuster medicine that would rival Merck's.
.png)
No hay comentarios:
Publicar un comentario